Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Evaluation of Epigenetic Drug Targeting of Heterogenous Tumor Cell Fractions Using Potential Biomarkers of Response in Ovarian Cancer
Formula: C5H4N4S
7-dihydroxy-
Gender differences in proximal esophageal contractions
43(9):1871-1879
Apremilast - CAS# 608141-41-9 Size:Solid 10 mg Evaluation of Epigenetic Drug TargetingApremilast, also known as CC 10004, is a thalidomide analog and is an orally available small molecule inhibitor of phosphodiesterase 4 (PDE4). Apremilast specifically inhibits PDE4 and inhibits spontaneous production of TNF alpha from human rheumatoid synovial cells. It has anti inflammatory activity. Apremilast was approved by the USFDA in March 2014 for treatment of adults with active psoriatic arthritis. It is also being tested for its efficacy in
US$ 2249.50
US$ 27.49
US$ 360.00
US$ 16.00
US$ 2249.50
US$ 649.50
US$ 165.00